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Outcome of endovascular repair of popliteal artery
aneurysm using the Viabahn endoprosthesis
Karan Garg, MD, Caron B. Rockman, MD, Billy J. Kim, MD, Glenn R. Jacobowitz, MD,
Thomas S. Maldonado, MD, Mark A. Adelman, MD, Frank J. Veith, MD, and Neal S. Cayne, MD,
New York, NY
Objective: This study reviews a single-center experience of endovascular popliteal aneurysm (PAA) repair.
Methods: A retrospective review was performed to identify all endovascular PAA repairs performed between September
2004 and January 2011.
Results:We identified 21 patients (mean age, 74  9 years, 91% men) with PAAs (mean size, 2.89  1.0 cm) in 26 limbs,
of which 38% were symptomatic. All patients underwent endovascular repair with a Viabahn covered stent graft (W. L.
Gore & Assoc, Inc, Flagstaff, Ariz). Postoperatively, all patients were maintained on antiplatelet therapy with clopidogrel
or aspirin, or both. Mean follow-up was 22 17 months (range, 1-57 months). One patient with one aneurysm was lost
to follow-up. Primary and secondary patencies were both 91.2% at 1 year and were 85.5% and 91.2%, respectively, at 2
years. The limb salvage rate was 100%. Four stent graft failures occurred at a mean of 12.3  11 months. One technical
failure due to stent graft infolding required conversion to an open femoral-popliteal bypass. Three additional graft
failures occurred in patients with poor (single-vessel) runoff. Compared with patients with two- or three-vessel runoff,
the graft failure rate in patients with single-vessel runoff was statistically significant (P  .02). Two of the graft failures
were successfully treated with open thrombectomy, and one required a tibial artery bypass for limb salvage.
Conclusions: Endovascular repair of PAAs is feasible and has acceptable midterm patency rates. Poor distal runoff
predicted graft failure. ( J Vasc Surg 2012;55:1647-53.)
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tPopliteal artery aneurysms (PAAs) are the most com-
mon peripheral artery aneurysm. They frequently present
bilaterally and are often found concurrently with other
aneurysms.1 Furthermore, these patients are at risk for
developing aneurysms in the future.1,2 Open repair with a
bypass or endoaneurysmorrhaphy is the gold standard, with
some series reporting limb salvage rates of90%.1,3-5 With
advancements in endovascular technology and fine-tuning
of techniques, increasing attention has been directed
toward repairing PAAs using an endovascular stent graft.
Endovascular repair of PAAs may offer numerous advan-
tages over open bypass. Possible advantages include
avoidance of general anesthesia, less blood loss, shorter
hospitalization, lower morbidity and mortality, and
faster functional recovery.
Marin et al6 reported the first successful endoluminal
treatment of a PAA with a stent graft in 1994, which was
patent at the 3-month follow-up. However, deploying a
stent graft across a joint undergoing constant flexion risks
graft migration, occlusion, or fracture. Such a location
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doi:10.1016/j.jvs.2011.12.059emands stent graft pliability. Advancements in endopros-
hesis technology have led to the development of such
exible self-expanding covered stents like the Wallgraft
Boston Scientific, Natick, Mass) and the Hemobahn and
iabahn (W. L. Gore & Associates Inc, Flagstaff, Ariz), and
hey have been used with success in repairing PAAs. We
eport our institutional experience with the use of endovas-
ular stent graft exclusion of PAAs.
ETHODS
A retrospective record review was performed on all
atients with the diagnosis of aneurysm of artery of lower
xtremity (International Classification of Disease code
42.3) at New York University Langone Medical Center
rom September 2004 to January 2011. All patients with a
AA who underwent endovascular repair were identified.
election criteria for patients offered an endovascular repair
ncluded those with adequate proximal and distal landing
ones and without extensive vessel tortuosity. Patients who
requently flexed the knee 90° for extended periods of
ime during activity or work and those with contraindica-
ions to antiplatelet therapy were generally excluded.
All repairs were performed with the Viabahn endopros-
hesis. Graft patency was defined as proven patency on
iagnostic imaging with computed tomography angiogra-
hy (CTA), duplex ultrasound (DU) imaging, or angiog-
aphy, or the presence of pedal artery pulses on physical
xamination. All patients were maintained on aspirin or
lopidogrel. Patient demographics, aneurysm characteris-
ics, operative findings, and outcomes were identified.
Standard statistical analysis was performed using SPSS
oftware (SPSS Inc, Chicago, Ill). Analysis with 2 or the
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categoric variables. A result was considered to be statisti-
cally significant with a value of P  .05.
Endovascular technique. All PAAs were evaluated
with preoperative imaging (Fig 1). The repairs were per-
formed in the operating room by vascular surgeons with the
patient under general, regional, or local anesthesia. Access
to the ipsilateral femoral artery was performed by cutdown
or percutaneous technique, depending on the surgeon’s
preference, using a 7F to 12F introducer sheath. An intra-
operative angiogram confirmed the location and size of the
PAA and the proximal and distal landing zones for the
placement of the stent graft (Fig 2).
The decision about the diameter of the Viabahn stent
graft was determined by the preoperative CTA and DU
imaging; however, additional fine-tuning of the size was
determined by the intraoperative angiography. The stent
graft was oversized 10% to 15% based on luminal diameter.
Aminimum length of 15mmwas achieved for the proximal
and distal landing zones in healthy vessels, avoiding signif-
icant collateral vessels when possible. In addition, before
determining the length of coverage, the knee was actively
bent under fluoroscopy to determine where the actual bend
of the artery and the landing zones would lie. This was
performed to avoid having the stent graft end right at the
bend of the popliteal artery, which might cause occlusion,
kinking, or migration. In long or tortuous segments of
PAAs requiring multiple stent graft placements, the distal
stent graft was placed first, followed by proximal stent grafts
with a minimum overlap of 20 mm.
After deployment of the stent graft, a noncompliant
balloon was used to mold the stent graft to achieve good
Fig 1. Preoperative computed tomography scan evaluates the
popliteal artery aneurysm.apposition to healthy vessel wall as well as between the overlapping stent grafts (Fig 3). A completion angiogram
as performed with and without the knee bent to evaluate
unoffs, kinks, or occlusions caused by the bending of the
nee (Figs 4-6).
Postoperative follow-up. All patients underwent
ostoperative follow-up at 1, 3, 6, and 12 months and then
early thereafter. Routine follow-up included clinical exam-
nation or color DU imaging. All patients underwent at
east one DU study1 year and thereafter at the discretion
ig 2. Intraoperative angiogram was used to assess proximal and
istal landing zones for the placement of the stent graft.
Fig 3. Stent deployment and ballooning.f the operating surgeon. In those patients who had wors-
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Volume 55, Number 6 Garg et al 1649ening clinical symptoms, elevated velocities on DU imag-
ing, or abnormal findings on physical examinations, further
studies, including CTA or angiography, were performed.
RESULTS
PAAs were treated in 26 limbs in 21 patients (19 men),
who were amean age of 74 9 years.Most aneurysms were
asymptomatic; however, 10 of 26 limbs (38%) had evidence
of thrombosis or embolization. One symptomatic aneu-
Fig 4. Postoperative angiogram.
Fig 5. Angiogram with bent knee.rysm underwent lysis before PAA repair. Additional patient Tharacteristics are listed in Table I. Three repairs were
ercutaneous, and 23 were through an open approach.
ocal anesthesia was used in 10 procedures, regional in
even, and general anesthesia in nine.
The mean preoperative PAA diameter was 2.89  1.0
m. The mean number of runoff vessels was 1.96  0.75.
ig 6. A completion angiogram performed with the knee bent
valuates runoffs, kinks, or occlusions in the stent.
able I. Patient characteristics
Variable
Mean  SD
No. (%)
Age, years 74  9
Male sex 19/21 (90.5)
Bilateral PAAs 10/21 (48)
History of AAAs 11/21 (52)
Pre-op PAA diameter, cm 2.89  1.0
Asymptomatic limbs 16/26 (62)
AA, Abdominal aortic aneurysm; PAA, popliteal artery aneurysm; SD,
tandard deviation.
able II. Operative considerations
Variable
No. (%) or
Mean  SD
Local anesthesia 10/26 (38)
Technical success 25/26 (96)
Crossing knee joint 24/25 (96)
Stents deployed, No. 1.8  1.1
Distal runoff, No. 1.96  0.75
Length of stay, days 2.4  2.4
Follow-up, months 22  17
D, Standard deviation.echnical success was 96%. One conversion to an open
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June 20121650 Garg et alfemoral-popliteal bypass was required secondary to graft
infolding during deployment, which has been previously
reported.7 A mean number of 1.9  1.1 stent grafts were
deployed in each limb. The mean length of stay was 2.1 
1.7 days.
The Viabahn endoprosthesis crossed the knee joint in
24 limbs (96%). Operative considerations are summarized
in Table II. Mean follow-up was 22  17 months (range,
1-57 months). One patient (one limb) was lost to follow-
up. Two deaths occurred during follow-up. Both patients
were aged 90 years old and were symptomatic at presen-
tation. The first death occurred 1 year postoperatively,
likely from cardiac causes, and the second, 2 months post-
operatively, from urosepsis unrelated to the surgery.
Primary and secondary patencies were both 91.2% at 1
year and were 85.5% and 91.2%, respectively, at 2 years by
Kaplan-Meier analysis (Fig 7 and Fig 8). Limb salvage was
100%. There were no cases of aneurysm rupture or embo-
lization. Four graft failures occurred at 12.3  11 months
(range, 0-26 months). One technical failure required con-
version to an open bypass intraoperatively. One patient’s
stent graft occluded 26 months after the repair of an
asymptomatically identified PAA, and he underwent a suc-
cessful open stent graft thrombectomy and balloon angio-
plasty. No stent graft thrombosis was evident at 35 months
of follow-up.
The second patient was initially transferred from an-
other institution with symptomatic thrombosis of his PAA,
which was initially treated with thrombolysis. At our insti-
tution, he underwent further thrombolysis, followed by
endovascular repair. Claudication developed 4 months af-
ter endovascular repair, and DU imaging confirmed stent
Fig 7. Kaplan-Meier (KMgraft thrombosis. The patient was initially managed conser- ratively but underwent a tibial bypass with a reversed
aphenous vein graft for a nonhealing ulcer 9 months after
is initial repair. On follow-up, his bypass was patent and
he ulcer had healed.
A third patient presented with acute stent graft
hrombosis 14 months after repair of his aneurysm.
pen thrombectomy successfully restored flow to his
eg, and the patient remained asymptomatic at follow-up
ith a patent stent graft. A day prior, the patient re-
orted prolonged bending at the knee joint while install-
ng a rug. Angiography was only notable for thrombosis
f the stent graft, without evidence of stent graft migra-
ion or fracture.
No stent graft migrations, fractures, or endoleaks were
oted on follow-up. Factors that could predispose to stent
raft occlusion were evaluated, including sex, number of
tent grafts deployed, runoff vessels, symptomatic vs
symptomatic aneurysms, and use of lipid-lowering agents.
he aneurysm lost to follow-up and the aneurysm requiring
ntraoperative conversion to an open bypass were both
xcluded from statistical analysis.
Compared with patients with two-vessel or three-vessel
unoff, the graft failure rate in patients with single-vessel
unoff was statistically significant (P  .02). In patients
ith poor runoff (single-vessel), three failures occurred in
ight patients. No occlusions developed in patients with
ood runoff: 10 patients had two-vessel runoff and six had
hree-vessel runoff. Additional factors evaluated were sex,
umber of stents deployed, aneurysm symptoms, and use of
ipid-lowering agents. Aside from runoff, no other factor
as statistically significant for stent graft occlusion. These
ve shows primary patency.esults are summarized in Table III.
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Operative repair is suggested for symptomatic PAAs,
aneurysms 2 cm, and those with the presence of mural
thrombus.8 Since the first reported case of a popliteal
aneurysm with an improvised graft was reported in 1994,
endovascular repair of PAAs has generated a lot of interest
among surgeons and interventionalists. Compared with a
peripheral bypass, an endovascular repair can offer the
advantages of quicker functional recovery, shorter hospital-
ization, minimal blood loss, and avoidance of general anes-
thesia. Endovascular repair of PAAs remains controversial,
however, and risks of stent graft occlusion, fracture, and
migration resulting in endoleaks raise concerns. In fact,
Fig 8. Kaplan-Meier (KM)
Table III. Predictors of stent graft occlusion
Predictor Variable
Patients
(No.)
Occlusions
(No.) P
Number of stents 1 11 1 .21
2 11 2
3 2 0
Antilipid therapy Yes 19 3 .34
No 5 0
Sex Male 22 3 .58
Female 2 0
Runoff vessels 1 8 3 .02a
2 or 3 16 0
Symptomatic Yes 8 2 .19
No 16 1
NS, Not significant.
aComparing patients with poor (1) vessel runoff and good (2 or 3) vessel
runoff.there are no U.S. Food and Drug Administration–ap- oroved stent grafts for repairing PAAs in the United States
t this time.
Most data on endovascular repair of PAAs are from case
eries reported during the last decade. Table IV lists the
arge series reported in the English literature during the last
ecade.9-20 Antonello et al13 reported the first prospective
andomized controlled trial comparing small numbers of
atients undergoing open and endovascular PAA repair.
hey demonstrated no statistically significant difference in
atency and limb salvage at a follow-up of4 years.13 In a
ollow-up study, with 6 years of follow-up, their results
ere similar, reporting a primary and secondary patency of
8% with open surgery compared with 71% and 86%,
espectively, in patients treated endovascularly.21 For en-
ovascular repair, they recommend avoiding oversizing
10% to 15%, using antiplatelet therapy, avoiding stent
raft overlap at critical points of flexion, and landing stent
rafts below the knee joint, leaving a tract of popliteal artery
or possible future bypass. Among their contraindications
as poor distal runoff, which is consistent with our data.
hey also advised against endovascular repair in the pres-
nce of thrombophilic disease.
A retrospective single-institution study has compared
pen and endovascular repair,17 and one meta-analysis has
ompared outcomes.22 Both studies demonstrated compa-
able midterm primary and secondary patency, with a
horter length of stay associated with endovascular repair.
he meta-analysis also noted that patients with PAAs un-
ergoing endovascular repair had statistically significant
igher reintervention rates at 30 days.22 More recently,
ina reported a cumulative summary of endovascular repair
e shows secondary patency.f PAAs and reported pooled estimates on patency rates.
s
s
a
v
s
i
b
b
C
e
y
r
c
r
a
f
s
v
p
d
v
A
C
A
D
W
C
F
S
O
O
R
JOURNAL OF VASCULAR SURGERY
June 20121652 Garg et alThe primary and secondary patency rates were, respectively,
83% and 86% at 1 year and 74% and 85% at 3 years, and were
comparable to patency achieved with open repair.23 A
further subgroup analysis of patients treated with Hemo-
bahn/Viabahn prostheses showed improved patency com-
pared with those treated with other stent grafts, although
the results were not statistically significant.
Open repair has been the standard of care for repairing
PAAs for many decades, and we have identified numerous
patient and technical factors contributing to successfully
performed repairs.24 We are just beginning to identify such
factors for endovascular repair for PAAs. For instance,
Tielliu et al14 reported their institutional experience, one of
the largest, on PAAs treated endovascularly. They noted
that most of their occlusions occurred early in the postop-
erative period. They initiated postoperative antiplatelet
therapy for their last 18 patients and reported no stent graft
occlusions. Furthermore, univariate analysis showed use of
antiplatelet therapy was a predictor of success.14 Since their
report in 2005, postoperative antiplatelet therapy has be-
come the standard of care, and improved patency rates are
reported (Table IV).
In our series, three occlusions occurred at a mean
follow-up of 22 months, all in patients with poor distal
runoff (single-vessel). Poor distal runoff is a predictor of
graft occlusion in open repair,5 and from our analysis, may
predispose to stent graft thrombosis in endovascular repair.
Arterial outflow must be critically evaluated before repair-
ing PAAs endovascularly, and somemay even consider poor
outflow as a contraindication.21
Additional factors, some of which have been shown to
affect graft patency in open repairs, would be worth scruti-
nizing for endovascular repairs, including asymptomatic vs
symptomatic clinical presentation, aneurysm length esti-
mated by use of the number of stent grafts, which would
affect landing zone; comorbidities affecting patency; and
use of lipid-lowering agents. As we continue to gain a better
understanding of these factors affecting stent graft patency,
clinicians must use their best judgment when proceeding
Table IV. Review of the literature for popliteal artery aneu
First author Year
Endo repairs
(No.)
Stent
(No.)
Henry9 2000 12 W, 1
Howell10 2002 13 W
Gerasimidis11 2003 9 H, 6; W, 2
Stone12 2005 7 W, 5; H, 2
Antonello13 2005 15 H
Tielliu14 2005 57 H/V
Mohan15 2006 30 H/V, 26
Rajasinghe16 2006 23 V
Curi17 2007 15 V
Idelchik18 2009 33 V/W
Midy19 2010 57 H/V, 42; W, 14
Jung20 2010 15 V
Garg 2011 26 V
H, Hemobahn, NR, not reported; V, Viabahn; W, Wallgraft.with endovascular repairs of PAAs. Furthermore, onehould be cognizant that open repair remains the gold
tandard.
Our series is limited in scope, being retrospective, with
n inherent selection bias because all patients offered endo-
ascular PAA repair had to meet certain predetermined
election criteria. Furthermore, the results of this single-
nstitutional experience at a tertiary referral center may not
e valid in a community setting. All findings must therefore
e interpreted within the context of these limitations.
ONCLUSIONS
There is increasing support in the literature favoring
ndovascular repair of PAAs. Careful patient selection can
ield midterm outcomes that are similar to open repair
eported elsewhere. Our study results show that those
onsidered for endovascular PAA repair should have good
unoff, be on postoperative antiplatelet therapy, and have
dequate landing zones. Long-term follow-up is needed
or patients treated endovascularly to see the incidence of
tent graft thrombosis, fracture, migration, and limb sal-
age. Further randomized studies are needed to identify
atient characteristics and the clinical situations to better
irect management of PAAs with open repair or an endo-
ascular approach.
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